Advertisement
Advertisement
Trending on Urology Times
1
Daniel George, MD, on the significance of the capivasertib approval for PTEN-deficient prostate cancer
2
FDA greenlights phase 1 study of UGN-501 for NMIBC
3
EV plus pembro approval reframes first conversation in MIBC diagnosis
4
Evidence Gaps in mCSPC
5